2026 NPPES data Gynecologic Oncology Physician NPI 1730189697 MD
Verify on CMS →

BONIFACE NDUBISI, MD

Gynecologic Oncology Physician in MARGATE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
112
Medicare Part D claims · 57 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$34.78
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BONIFACE NDUBISI, MD filed 112 Medicare Part D claims in 2023 as a Gynecologic Oncology Physician in MARGATE, Florida, prescribing 82% generic.

112
Part D claims, 2023
82%
generic prescribing
$34.78
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BONIFACE NDUBISI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

112 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

BONIFACE NDUBISI, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BONIFACE NDUBISI, MD?

Quality data not reported

NPI registry status

Active

Issued 07/21/2005

NPI 1730189697

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

112 40% vs specialty avg

2023 prescription claims

Specialty avg: 188

Specialty distribution in Florida

How Gynecologic Oncology Physician compares to other specialties among Florida providers

Florida providers

Gynecologic Oncology Physician share within Florida

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Gynecologic Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Gynecologic Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BONIFACE NDUBISI, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 2964 N STATE ROAD 7, MARGATE, FL, 33063, with a listed phone of (954) 974-5190. NPI 1730189697 was issued on 07/21/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NDUBISI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 112 prescription claims written by this provider, covering 57 Medicare beneficiaries and totaling roughly $5K in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2964 N STATE ROAD 7
MARGATE, FL 33063

Provider Details

NPI 1730189697
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Male
NPI Issued 07/21/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BONIFACE NDUBISI, MD. Source: openpaymentsdata.cms.gov.

Total received

$35

Largest payer

Astellas Pharma US Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to BONIFACE NDUBISI, MD. To verify BONIFACE NDUBISI, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

BONIFACE NDUBISI, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 112 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

112
Total Claims
$5K
Total Drug Cost
57
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
138
Total Day Supply
2,148
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$2K
Generic Drug Cost
$3K
Antibiotic Claims
31

Patient Demographics

Average Patient Age
71.8 years
Avg HCC Risk Score
1.52
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BONIFACE NDUBISI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levofloxacin
16
Fluconazole
15
Estradiol
13
Ciprofloxacin Hcl
11
Sod Sulf-Potass Sulf-Mag Sulf
"Sodium
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How BONIFACE NDUBISI, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

BONIFACE NDUBISI, MD's 112 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as NDUBISI.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BONIFACE NDUBISI, MD's specialty?
BONIFACE NDUBISI, MD specializes in Gynecologic Oncology Physician and practices in MARGATE, Florida. Credentials: MD.
How much does BONIFACE NDUBISI, MD prescribe under Medicare Part D?
In 2023, BONIFACE NDUBISI, MD wrote 112 Medicare Part D claims totaling $5K in drug costs for 57 beneficiaries.
Where is BONIFACE NDUBISI, MD located?
BONIFACE NDUBISI, MD is located at 2964 N STATE ROAD 7, MARGATE, FL, 33063. Phone: (954) 974-5190.
What is BONIFACE NDUBISI, MD's NPI number?
BONIFACE NDUBISI, MD's National Provider Identifier (NPI) is 1730189697, issued on 07/21/2005.
Does BONIFACE NDUBISI, MD prescribe more brand-name or generic drugs?
BONIFACE NDUBISI, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $2K in brand drug costs.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does BONIFACE NDUBISI, MD prescribe most often?
Based on 2023 Medicare Part D data, BONIFACE NDUBISI, MD's most frequently prescribed drugs include Levofloxacin, Fluconazole, Estradiol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BONIFACE NDUBISI, MD accept Medicare?
BONIFACE NDUBISI, MD appears in CMS Medicare data with 112 Part D claims and 57 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BONIFACE NDUBISI, MD's credentials?
BONIFACE NDUBISI, MD's NPI is 1730189697 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology